Comparing the Effectiveness of IV Bezlotoxumab Versus Placebo in Decreasing Morbidity and Mortality in Patients With Fulminant C. Diff Requiring Surgery.
Clinical trial NCT03756454 · TERMINATED
Trial details
- NCT number
- NCT03756454
- Sponsor
- Ohio State University
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-19
- Primary completion
- 2022-05-23
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.